The aim of this section of deliverable D9.2 is focused on the Ethics requirements for the use of human cells in InSilc projects. The rationale behind the use of human vascular cell types during InSilc experimentation of Task 3.3 is mainly to reproduce in vitro, in the cell culture environment, the dynamic in vivo conditions at both physiological blood flow regimen (without BVS) as well in the presence of an implanted BVS in patients with coronary artery disease.
INSILC D9.2. - HCT - Requirement No. 2
Vozzi Federico;Rocchiccioli Silvia;Pelosi Gualtiero
2018
Abstract
The aim of this section of deliverable D9.2 is focused on the Ethics requirements for the use of human cells in InSilc projects. The rationale behind the use of human vascular cell types during InSilc experimentation of Task 3.3 is mainly to reproduce in vitro, in the cell culture environment, the dynamic in vivo conditions at both physiological blood flow regimen (without BVS) as well in the presence of an implanted BVS in patients with coronary artery disease.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
